67 related articles for article (PubMed ID: 31375085)
1. Calothrixin B derivatives induce apoptosis and cell cycle arrest on HEL cells through the ERK/Ras/Raf/MEK pathway.
Wang B; Wang M; Li K; Wang C; Liu X; Rao Q; Song J; Hang Y; Liu S; Wen M; Huang L; Li Y
Biomed Pharmacother; 2024 Feb; 171():116179. PubMed ID: 38278023
[TBL] [Abstract][Full Text] [Related]
2. Limonoids from the roots of Melia azedarach and their anti-inflammatory activity.
Song M; Luo HJ; Li ZW; Qiu L; Zhao YX; He CW; Zhang XQ; Ye WC; Lin LG; Zhang QW
Phytochemistry; 2023 Dec; 216():113869. PubMed ID: 37739201
[TBL] [Abstract][Full Text] [Related]
3. Navigating the ERK1/2 MAPK Cascade.
Martin-Vega A; Cobb MH
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892237
[TBL] [Abstract][Full Text] [Related]
4. Exploring research trends and priorities of genus Melia.
S SR; Arunachalam A; Sahoo UK; Upadhyaya K
Sci Rep; 2024 Mar; 14(1):6265. PubMed ID: 38490998
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate.
Hu M; Xu M; Chen Y; Ye Z; Zhu S; Cai J; Zhang M; Zhang C; Huang R; Ye Q; Ao H
Biomed Pharmacother; 2023 Nov; 167():115541. PubMed ID: 37738795
[TBL] [Abstract][Full Text] [Related]
6. Natural products targeting the MAPK-signaling pathway in cancer: overview.
Shi A; Liu L; Li S; Qi B
J Cancer Res Clin Oncol; 2024 Jan; 150(1):6. PubMed ID: 38193944
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in megakaryocytes: Safeguard and threat for thrombopoiesis.
Yang S; Wang L; Wu Y; Wu A; Huang F; Tang X; Kantawong F; Anuchapreeda S; Qin D; Mei Q; Chen J; Huang X; Zhang C; Wu J
Front Immunol; 2022; 13():1025945. PubMed ID: 36685543
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling.
Gao J; Hu J; Yu F; Wang C; Sheng D; Liu W; Hu A; Yu K; Xiao X; Kuang Y; Zacksenhaus E; Gajendran B; Ben-David Y
BMC Cancer; 2023 Apr; 23(1):306. PubMed ID: 37016335
[TBL] [Abstract][Full Text] [Related]
9. The Application of Ethnomedicine in Modulating Megakaryocyte Differentiation and Platelet Counts.
Yang F; Lai J; Deng J; Du J; Du X; Zhang X; Wang Y; Huang Q; Xu Q; Yang G; Zhang Y; Zhou X; Zhang X; Yuan Y; Zhang C; Wu J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834579
[TBL] [Abstract][Full Text] [Related]
10. Predicting suitable habitats of Melia azedarach L. in China using data mining.
Feng L; Tian X; El-Kassaby YA; Qiu J; Feng Z; Sun J; Wang G; Wang T
Sci Rep; 2022 Jul; 12(1):12617. PubMed ID: 35871227
[TBL] [Abstract][Full Text] [Related]
11. ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes.
Yu F; Gajendran B; Wang N; Sample KM; Liu W; Wang C; Hu A; Zacksenhaus E; Hao X; Ben-David Y
BMC Cancer; 2021 Jun; 21(1):680. PubMed ID: 34107900
[TBL] [Abstract][Full Text] [Related]
12. A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3.
Gajendran B; Varier KM; Liu W; Wang C; Sample KM; Zacksenhaus E; Juiwei C; Huang L; Hao X; Ben-David Y
Commun Biol; 2020 Dec; 3(1):732. PubMed ID: 33273692
[TBL] [Abstract][Full Text] [Related]
13. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
Wang N; Fan Y; Yuan CM; Song J; Yao Y; Liu W; Gajendran B; Zacksenhaus E; Li Y; Liu J; Hao XJ; Ben-David Y
BMC Cancer; 2019 Aug; 19(1):764. PubMed ID: 31375085
[TBL] [Abstract][Full Text] [Related]
14. 1-Cinnamoyltrichilinin from
Jeong H; Park S; Kim SY; Cho SH; Jeong MS; Kim SR; Seo JB; Kim SH; Kim KN
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053881
[TBL] [Abstract][Full Text] [Related]
15. Three new and other limonoids from the hexane extract of Melia azedarach fruits and their cytotoxic activities.
Pan X; Matsumoto M; Nakamura Y; Kikuchi T; Zhang J; Ukiya M; Suzuki T; Koike K; Akihisa R; Akihisa T
Chem Biodivers; 2014 Jul; 11(7):987-1000. PubMed ID: 25044585
[TBL] [Abstract][Full Text] [Related]
16. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
Liu T; Yao Y; Zhang G; Wang Y; Deng B; Song J; Li X; Han F; Xiao X; Yang J; Xia L; Li YJ; Plachynta M; Zhang M; Yan C; Mu S; Luo H; Zacksenhaus E; Hao X; Ben-David Y
Oncotarget; 2017 Mar; 8(10):16728-16743. PubMed ID: 28052010
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of icaritin and the molecular mechanisms.
Zhang C; Sui X; Jiang Y; Wang X; Wang S
Discov Med; 2020; 29(156):5-16. PubMed ID: 32598859
[TBL] [Abstract][Full Text] [Related]
18. ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.
Sugiura R; Satoh R; Takasaki T
Cells; 2021 Sep; 10(10):. PubMed ID: 34685488
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
